Exos Asset Management’s Celularity CELU Stock Holding History

Exos Asset Management’s Portfolio CELU Stock Details CELU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-600	Closed	-$66K	–	440
2020 Q4	$66K	Buy	+600	New	+$63.8K	0.11%	153

Other funds holding CELU

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

WRBC

W.R. Berkley Corp Greenwich, Connecticut $1.86B AUM 14.44% 1-Year Est. Return

BCM

BlueCrest Capital Management St Helier, Jersey $1.69B AUM 20.01% 1-Year Est. Return

TAL

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

MSU

Mizuho Securities USA New York $4.24B AUM 23.1% 1-Year Est. Return

HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

WAM

Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return

Exos Asset Management's CELU Position: Q1 2021 in Review

Exos Asset Management sold out of Celularity (CELU) in Q1 2021, closing a stake of 600 shares — an estimated $66K sold.

Exos Asset Management first reported a position in CELU in Q4 2020 and held it in 1 quarter. The position peaked at $66K in Q4 2020. 63 funds tracked by Wall St. Rank hold CELU as of Q1 2021.

Exos Asset Management reported no remaining Celularity position as of Q1 2021 after selling out during the quarter.
Exos Asset Management sold 600 Celularity shares in Q1 2021, an estimated $66K.
Exos Asset Management first reported a position in Celularity in Q4 2020 and held it in 1 quarter.
Exos Asset Management's Celularity position peaked at $66K in Q4 2020.
63 funds tracked by Wall St. Rank held Celularity as of Q1 2021.

Based on Exos Asset Management's 13F filing for Q1 2021, filed 5 May 2021.